Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances Insights from the Society of Infectious Diseases Pharmacists-Reference-Cited by-同舟云学术

Coinfection with Human Immunodeficiency Virus and Hepatitis C Virus: Challenges and Therapeutic Advances Insights from the Society of Infectious Diseases Pharmacists

Published:2011-04 Issue:4 Volume:31 Page:357-368
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Deming Paulina,McNicholl Ian R

Publisher

Wiley

Subject

Pharmacology (medical)

Reference41 articles.

1. Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

2. Hepatitis C and Progression of HIV Disease

3. Viral hepatitis and HIV coinfection

4. Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus

5. Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Peptides as Anti-Influenza Agents;International Journal of Molecular Sciences;2022-09-28

2. Antiviral peptidlerin SARS COV-2 ana proteaz yapısına bağlanma etkinliklerinin protein-yanaştırma yöntemi ile incelenmesi: In silico bir çalışma;Frontiers in Life Sciences and Related Technologies;2022-09-27

3. Antiviral peptides as promising therapeutic drugs;Cellular and Molecular Life Sciences;2019-05-17

4. Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection;Biomaterials;2013-05

5. Focus on drug interactions;Current Opinion in Infectious Diseases;2013-02